DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease (2023)
- Authors:
- Souza, Márcia Maria de
- Cenci, Arthur Ribeiro - Universidade Federal de Santa Catarina (UFSC)
- Teixeira, Kerolain Faoro - Universidade Federal de Santa Catarina (UFSC)
- Machado, Valkiria - Universidade Federal de Santa Catarina (UFSC)
- Mendes, Majory Christina Garcia - Universidade Federal de Santa Catarina (UFSC)
- Gonçalves, Ana Elisa
- Dalmagro, Ana Paula
- Cazarin, Camila André
- Ferreira, Leonardo Luiz Gomes
- Oliveira, Aldo Sena de
- Andricopulo, Adriano Defini
- USP affiliated authors: FERREIRA, LEONARDO LUIZ GOMES - IFSC ; ANDRICOPULO, ADRIANO DEFINI - IFSC ; OLIVEIRA, ALDO SENA DE - IFSC
- Unidade: IFSC
- DOI: 10.2174/0929867329666220620162018
- Subjects: DOENÇA DE ALZHEIMER; INIBIDORES DE ENZIMAS
- Keywords: Alzheimer's disease; Neurodegeneration; Protein kinases; Enzyme kinetics; DYRK1A inhibitors; Molecular docking
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Current Medicinal Chemistry
- ISSN: 0929-8673
- Volume/Número/Paginação/Ano: v. 30, n. 6, p. 669-688, 2023
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SOUZA, Márcia Maria de et al. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease. Current Medicinal Chemistry, v. 30, n. 6, p. 669-688, 2023Tradução . . Disponível em: https://doi.org/10.2174/0929867329666220620162018. Acesso em: 03 jun. 2024. -
APA
Souza, M. M. de, Cenci, A. R., Teixeira, K. F., Machado, V., Mendes, M. C. G., Gonçalves, A. E., et al. (2023). DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease. Current Medicinal Chemistry, 30( 6), 669-688. doi:10.2174/0929867329666220620162018 -
NLM
Souza MM de, Cenci AR, Teixeira KF, Machado V, Mendes MCG, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2024 jun. 03 ] Available from: https://doi.org/10.2174/0929867329666220620162018 -
Vancouver
Souza MM de, Cenci AR, Teixeira KF, Machado V, Mendes MCG, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2024 jun. 03 ] Available from: https://doi.org/10.2174/0929867329666220620162018 - Molecular docking and quantum studies of lawsone dimers derivatives: new investigation of antioxidant behavior and antifungal activity
- Quantitative structure-activity relationships for structurally diverse chemotypes having anti-Trypanosoma cruzi activity
- Novel brominated vinylic fatty acids effectively inhibit the leishmania topoisomerase IB enzyme mediated by halogen bond formation
- 3D QSAR studies for a series of Trypanosoma cruzi dehydrogenase inhibitors
- Saúde e bem-estar
- Structure-activity relationships of sulfonamides derived from carvacrol as new agents for the treatment of Alzheimer's disease
- World chagas disease day and the new road map for neglected tropical diseases. [Editorial]
- Medicamentos e tratamentos para a Covid-19
- Structure-based drug design
- Cancer estimates in Brazil reveal progress for the most lethal malignancies [Editorial]
Informações sobre o DOI: 10.2174/0929867329666220620162018 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | PROD033747_3111047.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
